News on Vancomycin from BioPortfolio.com http://www.BioPortfolio.com Consolidated Vancomycin news from BioPortfolio.com Wed, 10 Feb 2010 02:49:07 GMT en 5 Dayshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032661&HITNO=0&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032661&THISHREF=http://c.moreover.com/click/here.pl%3fz2534755585%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032661&HITNO=0&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032661&THISHREF=http://c.moreover.com/click/here.pl%3fz2534755585%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAdvance for Nurses: Clinical Characteristics, Outcomes, and Microbiologic Features Associated with Methicillin-Resistant Staphylococcus aureus Bacteremia in Pediatric Patients Treated with Vancomycinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034176&HITNO=1&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034176&THISHREF=http://c.moreover.com/click/here.pl%3fz2535672643%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034176&HITNO=1&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034176&THISHREF=http://c.moreover.com/click/here.pl%3fz2535672643%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Optimer shares buoyed by promising Ph3 C. diff datahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022627&HITNO=2&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022627&THISHREF=http://c.moreover.com/click/here.pl%3fz2527765169%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022627&HITNO=2&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022627&THISHREF=http://c.moreover.com/click/here.pl%3fz2527765169%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFierceBiotech: Reports summarize clostridium therapy study results from I. Lowy and co-researchershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010025&HITNO=3&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010025&THISHREF=http://c.moreover.com/click/here.pl%3fz2522201816%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010025&HITNO=3&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010025&THISHREF=http://c.moreover.com/click/here.pl%3fz2522201816%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Adding Rifampicin to Vancomycin May Improve Outcome of MRSA Pneumoniahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007822&HITNO=4&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007822&THISHREF=http://c.moreover.com/click/here.pl%3fz2521299367%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007822&HITNO=4&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007822&THISHREF=http://c.moreover.com/click/here.pl%3fz2521299367%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAbstracts in Hematology and Oncology: Adding Rifampicin to Vancomycin May Improve Outcome of MRSA Pneumoniahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006993&HITNO=5&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006993&THISHREF=http://c.moreover.com/click/here.pl%3fz2520961317%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006993&HITNO=5&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006993&THISHREF=http://c.moreover.com/click/here.pl%3fz2520961317%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedscape: Ecolab launches EnCompass Environmental Hygiene program to improve patient room hygienehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995624&HITNO=6&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995624&THISHREF=http://c.moreover.com/click/here.pl%3fz2515790565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995624&HITNO=6&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995624&THISHREF=http://c.moreover.com/click/here.pl%3fz2515790565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Hospitals Report Low Compliance With Antibiotic Prophylaxis Guidelines, Australiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990539&HITNO=7&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990539&THISHREF=http://c.moreover.com/click/here.pl%3fz2513351438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990539&HITNO=7&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990539&THISHREF=http://c.moreover.com/click/here.pl%3fz2513351438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Ecolab Introduces New Hospital Program to Improve Hygiene in Patient Roomshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993201&HITNO=8&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993201&THISHREF=http://c.moreover.com/click/here.pl%3fz2514489799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993201&HITNO=8&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993201&THISHREF=http://c.moreover.com/click/here.pl%3fz2514489799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Ecolab Introduces New Hospital Program to Improve Hygiene in Patient Roomshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3992670&HITNO=9&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3992670&THISHREF=http://c.moreover.com/click/here.pl%3fz2514285494%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3992670&HITNO=9&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3992670&THISHREF=http://c.moreover.com/click/here.pl%3fz2514285494%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis cathetershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990228&HITNO=10&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990228&THISHREF=http://c.moreover.com/click/here.pl%3fz2513214664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990228&HITNO=10&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990228&THISHREF=http://c.moreover.com/click/here.pl%3fz2513214664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Therapeutic Options for [Diabetes-Related] Foot Infectionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980454&HITNO=11&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980454&THISHREF=http://c.moreover.com/click/here.pl%3fz2506406237%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980454&HITNO=11&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980454&THISHREF=http://c.moreover.com/click/here.pl%3fz2506406237%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAAPS Pharmceutica: Theravance Announces Receipt of Additional FDA Communication Regarding Telavancin NDA for the Treatment of Noshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984250&HITNO=12&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984250&THISHREF=http://c.moreover.com/click/here.pl%3fz2508066312%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984250&HITNO=12&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984250&THISHREF=http://c.moreover.com/click/here.pl%3fz2508066312%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: FDA Seeks More Data For Theravance, Inc. (THRX) Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983590&HITNO=13&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983590&THISHREF=http://c.moreover.com/click/here.pl%3fz2507822719%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983590&HITNO=13&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983590&THISHREF=http://c.moreover.com/click/here.pl%3fz2507822719%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Theravance Announces Receipt of Additional FDA Communication Regarding Telavancin NDA for the Treatment of Noshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980063&HITNO=14&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980063&THISHREF=http://c.moreover.com/click/here.pl%3fz2506199170%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980063&HITNO=14&MSIZE=86&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Vancomycin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980063&THISHREF=http://c.moreover.com/click/here.pl%3fz2506199170%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: